Process for preparation of 9-hydroxy-3-(2-chloroethyl)-2-methyl-4H-pyrido[1,2-A]pyrimidin-4-one hydrochloride
View Patent ↗Described herein is an improved, commercially viable and industrially advantageous process for the preparation of paliperidone intermediate 9-hydroxy-3-(2-chloroethyl)-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one and its hydrochloride salt. The process provides the paliperidone intermediate in higher yield and reduced reaction time compared to the previously disclosed processes, thereby providing for production of paliperidone and its pharmaceutically acceptable acid addition salts in high purity and in high yield.
1. A process for preparation of 9-hydroxy-3-(2-chloroethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one of formula I:
or its hydrochloride salt thereof comprising:
a) reacting 2-amino-3-hydroxypyridine of formula II:
with 2-acetylbutyrolactone of formula III:
in the presence of phosphorous oxychloride to form a reaction mass;
b) quenching the reaction mass obtained in step-(a) in a mixture of ice and water to form a quenched reaction mass;
c) adjusting the pH of the quenched reaction mass to 4 - 6 with a base to produce a separated substantially pure compound of formula I;
d) collecting the separated substantially pure compound of formula I; and
e) optionally converting the separated substantially pure compound of formula I into its substantially pure hydrochloride salt by reacting the separated substantially pure compound of formula I with alcoholic or gaseous hydrogen chloride in a solvent selected from an alcoholic solvent and an aromatic solvent.
2. The process of claim 1 , wherein the reaction in step-(a) is carried out at a temperature of 20° C. to 70° C.
3. The process of claim 1 , wherein 1 to 2 equivalents of 2-acetylbutyro-lactone of formula III per equivalent of 2-amino-3-hydroxypyridine of formula II is used in step-(a).
4. The process of claim 3 , wherein 1 to 1.3 equivalents of 2-acetylbutyro-lactone per equivalent of the 2-amino-3-hydroxypyridine is used.
5. The process of claim 1 , wherein 2.4 to 7 equivalents of phosphorous oxychloride per equivalent of 2-amino-3-hydroxypyridine of formula II is used in step-(a).
6. The process of claim 5 , wherein 3 to 4 equivalents of phosphorous oxychloride per equivalent of 2-amino-3-hydroxypyridine is used.
7. The process of claim 1 , wherein the pH of the reaction mass in step-(c) is adjusted to 5 - 6; and wherein the base used is an organic or an inorganic base.
8. The process of claim 7 , wherein the inorganic base is selected from the group consisting of aqueous ammonia, sodium hydroxide, potassium hydroxide, magnesium hydroxide, magnesium oxide, sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, sodium tert-butoxide, potassium tert-butoxide, and combinations of the foregoing bases.
9. The process of claim 8 , wherein the inorganic base is aqueous ammonia.
10. The process of claim 1 , wherein the compound of formula I obtained in step-(d) has a purity of about 97% to about 99.5% as measured by HPLC.
11. The process of claim 1 , wherein the alcoholic solvent used in step-(e) is selected from the group consisting of methanol, ethanol, n-propanol, 2-propanol, n-butanol, tert-butanol and combinations thereof; and wherein the aromatic solvent is selected from the group consisting of toluene, xylene and combinations thereof.
12. The process of claim 11 , wherein the alcoholic solvent is methanol; and wherein the aromatic solvent is toluene.
13. The process of claim 1 , wherein the alcoholic hydrogen chloride used in step-(e) is methanolic hydrogen chloride.